Clinicopathological analysis of osteofibrous dysplasia and adamantinoma: A single institution experience

Key Points

• Osteofibrous dysplasia and adamantinoma show distinct clinicopathological features, influencing patient management and treatment decisions.
• Analysis of 40 patients over a decade highlights the importance of accurate biopsy for diagnosis and effective treatment planning.
• Comparative assessment using histopathology illustrates the differences in tumor behavior and outcomes, with implications for follow-up care.
• Findings may enable enhanced strategies for handling osteofibrous dysplasia and adamantinoma, but results require validation in larger studies.